While the inflammation-reducing and fibrosis-attenuating effects of glucagon agonism are less well-characterized, the reductions in hepatic inflammation parameters and fibrosis observed in preclinical models likely reflect secondary effects consequent to improved steatosis, rather than direct anti-inflammatory actions [21]
This case closely parallels our own, reinforcing the need for clinicians to recognize semaglutide as a potential cause of gastroparesis, particularly in diabetic patients, and to promptly withdraw the medication to facilitate recovery and avoid unnecessary interventions
Inhibition of the bacterial heme oxygenases from Pseudomonas aeruginosa and Neisseria meningitidis: novel antimicrobial targets
It is studied for anti inflammatory signalling effects in cellular and preclinical models, including NF kappa B related pathway readouts, cytokine panels, and epithelial barrier marker sets
Sowers, Jun Ren Pharmacology & Therapeutics.2018
According to NICE guidance and UK product licences, GLP-1 treatment for weight management should be discontinued if you haven't achieved at least 5% weight loss after 12 weeks on the maintenance dose